"Washington should heed the demand of voters to focus on issues impacting their pocketbook while also living up to the responsibility entrusted in elected leaders to be stewards of our nation’s fiscal future."
Cognition Therapeutics, Inc. announced that on November 3, 2026, it received a deficiency letter from the Nasdaq Listing Qualifications Department because the closing bid price for its common stock had been below the minimum $1.00 per share required for continued listing for 30 c
Haemonetics Corporation reported financial results for its second quarter of fiscal 2027, which ended September 26, 2026. Second quarter fiscal 2027 revenue was $357.8 million, up 9.3% compared with the second quarter of fiscal 2026. Second quarter organic revenue growth was 10.0
Toyota Motor Corporation announced that its board of directors has resolved to partially amend its share repurchase program, originally authorized on August 4, 2026. The amendment increases the maximum number of shares to be repurchased from 500 million shares to 610 million shar
The S&P 500 Index ($SPX ) (SPY ) closed up +1.58% on Wednesday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +3.03%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.91%. December E-mini S&P futures (ESZ26 ) rose +1.60%, and December E-mini Nasdaq futures...
Fox News' Jesse Watters warned most Democrats still want to target President Donald Trump despite signaling they will work with him in the next Congress.
The S&P 500 Index ($SPX ) (SPY ) closed up +1.58% on Wednesday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +3.03%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.91%. December E-mini S&P futures (ESZ26 ) rose +1.60%, and December E-mini Nasdaq futures...
Orthofix (OFIX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Alcon (ALC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.